Press release
Subcutaneous Drug Delivery Devices Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Pen Injectors, Auto Injectors, Wearable Injectors, Needle-free Injectors), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Market Outlook And Industry Analysis 2031"
The Global Subcutaneous Drug Delivery Devices Market is valued at US$ 30.9 Bn in 2023, and it is expected to reach US$ 55.7 Bn by 2031, with a CAGR of 7.9% during the forecast period of 2024-2031.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/2849
This market is likely to boom in the future years due to technological advances and a tremendous burden of chronic diseases. The subcutaneous drug delivery devices are intended for direct delivery of drugs into the subcutaneous tissue in a controlled manner, convenient, and relatively painless as compared with conventional injection methods. The key types of subcutaneous devices include prefilled syringes that can deliver fast and accurate dosing, auto-injectors designed for self-administration, pen injectors very commonly used to deliver insulin, wearable injectors designed to provide continuous dosing, and needle-free injectors that minimize discomfort by relying on high-pressure technology.
The subcutaneous drug delivery devices include diabetes management with the help of insulin pens and pumps, oncology treatments for the administration of chemotherapy and immunotherapy, hormone injection fertility treatments, and emergency care through auto-injectors such as EpiPens. The main importance of the subcutaneous drug delivery device is better patient outcome as it delivers self-administration of medicines which limits the frequent attendance of healthcare services and allows the patient to take care of the treatment. For example, real-time monitoring smart devices improve both patient experience and compliance.
List of Prominent Players in the Subcutaneous Drug Delivery Devices Market:
• Gerresheimer AG
• Medtronic Plc
• Ypsomed AG
• Elcam Medical Group
• Novo Nordisk
• Insulet Corporation
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• PharmaJet
• Unilife Corporation
• Inolife Sciences
Market Dynamics:
Drivers-
A strong growth in diseases such as diabetes, rheumatoid arthritis, and cardiovascular diseases is the major growth driver for the subcutaneous drug delivery devices market. As highlighted by the National Diabetes Statistics Report, 38.4 million people of all ages-or 11.6% of the U.S. population-had diabetes underlines the increasing demand for effective management solutions such as insulin pens and auto-injectors. Technological innovations, like smart devices with real-time monitoring capabilities, help improve drug adherence and correct dosing; this promotes the overall trend toward personalized medicine. Due to the upsurge for self-administered medications, especially for chronic diseases, patients can basically treat themselves without going to the healthcare center, which thereby grows the market. Awareness and education on advanced drug delivery methods and its benefits also increase the adoption rates in case of improved patient outcome.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2849
Challenges:
The major challenges that the subcutaneous drug delivery devices market is facing are it has lengthy and costly regulatory approval processes, especially in regions such as the U.S. and Europe, which may hinder the entrance of new products into the market; it involves pricey research, testing, and innovation development expenses that may limit entry by smaller companies into the competitive market. The last challenge is at the technological level where some of the technological challenges such as accurate dosing, reducing discomfort on the patient's side, require very strong developments in microelectronics and material science. Developing these medical devices is complicated and demanding.
Regional Trends:
North America stands at the forefront of subcutaneous drug delivery devices, primarily due to an advanced healthcare infrastructure, high prevalence rates for chronic diseases, significant investments in research and development, and a supportive regulatory framework. The region, which has already acquired a well-developed healthcare system empowered with cutting-edge technology, will embrace new subcutaneous delivery devices. Other widespread chronic conditions include diabetes, which affects 38.4 million Americans as of the year 2021, hence the demand for such useful management tools like the insulin pen and auto-injector. The investments put into R&D by North America pharmaceutical and medical device companies have driven technological advancements that improve patient compliance and outcomes of treatment. Reimbursement policies favoring the same are also in support and make the devices more accessible to patients at affordable prices.
Recent Developments:
• In March 2022, Novo Nordisk announced that the FDA has approved a 2.0 mg dose of Ozempic (semaglutide), a once-weekly subcutaneous GLP-1 analogue, for treating adults with type 2 diabetes.
• In Aug 2024, Medtronic plc announced FDA approval for its Simplera™ continuous glucose monitor (CGM), the company's first disposable, all-in-one CGM, which is half the size of previous models. Its discreet design simplifies insertion and wear, eliminating the need for overtape.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2849
Segmentation of Subcutaneous Drug Delivery Devices Market-
By Product:
• Prefilled Syringes
• Pen Injectors
• Auto Injectors
• Wearable Injectors
• Needle-free Injectors
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/subcutaneous-drug-delivery-devices-market/2849
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
The Global Subcutaneous Drug Delivery Devices Market is valued at US$ 30.9 Bn in 2023, and it is expected to reach US$ 55.7 Bn by 2031, with a CAGR of 7.9% during the forecast period of 2024-2031.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/2849
This market is likely to boom in the future years due to technological advances and a tremendous burden of chronic diseases. The subcutaneous drug delivery devices are intended for direct delivery of drugs into the subcutaneous tissue in a controlled manner, convenient, and relatively painless as compared with conventional injection methods. The key types of subcutaneous devices include prefilled syringes that can deliver fast and accurate dosing, auto-injectors designed for self-administration, pen injectors very commonly used to deliver insulin, wearable injectors designed to provide continuous dosing, and needle-free injectors that minimize discomfort by relying on high-pressure technology.
The subcutaneous drug delivery devices include diabetes management with the help of insulin pens and pumps, oncology treatments for the administration of chemotherapy and immunotherapy, hormone injection fertility treatments, and emergency care through auto-injectors such as EpiPens. The main importance of the subcutaneous drug delivery device is better patient outcome as it delivers self-administration of medicines which limits the frequent attendance of healthcare services and allows the patient to take care of the treatment. For example, real-time monitoring smart devices improve both patient experience and compliance.
List of Prominent Players in the Subcutaneous Drug Delivery Devices Market:
• Gerresheimer AG
• Medtronic Plc
• Ypsomed AG
• Elcam Medical Group
• Novo Nordisk
• Insulet Corporation
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• PharmaJet
• Unilife Corporation
• Inolife Sciences
Market Dynamics:
Drivers-
A strong growth in diseases such as diabetes, rheumatoid arthritis, and cardiovascular diseases is the major growth driver for the subcutaneous drug delivery devices market. As highlighted by the National Diabetes Statistics Report, 38.4 million people of all ages-or 11.6% of the U.S. population-had diabetes underlines the increasing demand for effective management solutions such as insulin pens and auto-injectors. Technological innovations, like smart devices with real-time monitoring capabilities, help improve drug adherence and correct dosing; this promotes the overall trend toward personalized medicine. Due to the upsurge for self-administered medications, especially for chronic diseases, patients can basically treat themselves without going to the healthcare center, which thereby grows the market. Awareness and education on advanced drug delivery methods and its benefits also increase the adoption rates in case of improved patient outcome.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2849
Challenges:
The major challenges that the subcutaneous drug delivery devices market is facing are it has lengthy and costly regulatory approval processes, especially in regions such as the U.S. and Europe, which may hinder the entrance of new products into the market; it involves pricey research, testing, and innovation development expenses that may limit entry by smaller companies into the competitive market. The last challenge is at the technological level where some of the technological challenges such as accurate dosing, reducing discomfort on the patient's side, require very strong developments in microelectronics and material science. Developing these medical devices is complicated and demanding.
Regional Trends:
North America stands at the forefront of subcutaneous drug delivery devices, primarily due to an advanced healthcare infrastructure, high prevalence rates for chronic diseases, significant investments in research and development, and a supportive regulatory framework. The region, which has already acquired a well-developed healthcare system empowered with cutting-edge technology, will embrace new subcutaneous delivery devices. Other widespread chronic conditions include diabetes, which affects 38.4 million Americans as of the year 2021, hence the demand for such useful management tools like the insulin pen and auto-injector. The investments put into R&D by North America pharmaceutical and medical device companies have driven technological advancements that improve patient compliance and outcomes of treatment. Reimbursement policies favoring the same are also in support and make the devices more accessible to patients at affordable prices.
Recent Developments:
• In March 2022, Novo Nordisk announced that the FDA has approved a 2.0 mg dose of Ozempic (semaglutide), a once-weekly subcutaneous GLP-1 analogue, for treating adults with type 2 diabetes.
• In Aug 2024, Medtronic plc announced FDA approval for its Simplera™ continuous glucose monitor (CGM), the company's first disposable, all-in-one CGM, which is half the size of previous models. Its discreet design simplifies insertion and wear, eliminating the need for overtape.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2849
Segmentation of Subcutaneous Drug Delivery Devices Market-
By Product:
• Prefilled Syringes
• Pen Injectors
• Auto Injectors
• Wearable Injectors
• Needle-free Injectors
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/subcutaneous-drug-delivery-devices-market/2849
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
